Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · SEI

Arga International Value Fund Institutional Shares (ARVIX)

Ticker ARVIX · · Holdings as of Jun 30, 2026

Expense ratio
0.75%$75/yr per $10k
1-yr return
+39.7%as of Dec 2025
Net assets
$177.6Mall share classes
Holdings
78

Bottom line

Is ARVIX a good fund? The bottom line

ARVIX is the Institutional share class of Arga International Value Fund, an actively managed international stock mutual fund from SEI.

Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 67% of international stock funds we track.

It returned +39.7% over one year (as of Dec 31, 2025, per its prospectus).

With $178 million in net assets and 78 holdings, its largest position is Prosus N.V. (5.0%) and the top 10 make up 35.1% of the portfolio.

Updated Nov 19, 2026

What ARVIX invests in

The ARGA International Value Fund (the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Fund invests primarily in equity securities of companies located in any part of the world and in other instruments, such as shares of exchange-traded funds (ETFs), that have economic characteristics similar to such securities. The Fund mainly invests in common stocks, but may also invest in depositary receipts (including American Depositary Receipts (ADRs), European Depositary Receipts (EDRs) and Global Depositary Receipts (GDRs)), preferred stocks, participation notes (P-Notes), private placements, ETFs and real estate investment trusts (REITs). Depositary receipts are certificates typically issued by a bank or trust company that represent ownership interests in securities of non-U.S. companies. Typically, the Fund invests in securities of companies with a market capitalization of at least $1 billion. The Fund may invest in securities denominated in any…

From the fund's prospectus (filed Apr 30, 2026).

ARVIX performance

Fund calendar-year total returns, 2022–2025 2022: −3.9%; 2023: +23.1%; 2024: +1.2%; 2025: +39.7% −3.9% 2022 +23.1% 2023 +1.2% 2024 +39.7% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
ARVIX+39.7%——
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full ARVIX performance history →

What ARVIX costs

On a $10,000 investment, ARVIX's 0.75% expense ratio costs about $75 a year. The prospectus estimates $1,018 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full ARVIX fee table →

ARVIX top 10 holdings

#Holding% of fund
1Prosus N.V.4.97%
2Kering Sa4.57%
3Nidec Corporation4.56%
4Bayer Aktiengesellschaft3.94%
5Novo Nordisk A/s3.40%
6Rheinmetall Aktiengesellschaft3.10%
7Gsk Plc3.09%
8AerCap Holdings N.V.3.04%
9Sika AG2.22%
10Axa Sa2.17%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 35.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to ARVIX

More funds like ARVIX →

ARVIX FAQ

What is the expense ratio of ARVIX?
ARVIX's expense ratio is 0.75%, which works out to about $75 a year for every $10,000 invested. The prospectus estimates total costs of $1,018 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ARVIX a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does ARVIX hold?
ARVIX's largest holdings are Prosus N.V. (5.0%), Kering Sa (4.6%), Nidec Corporation (4.6%), Bayer Aktiengesellschaft (3.9%), Novo Nordisk A/s (3.4%). It holds 78 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages ARVIX?
ARVIX is offered by SEI through Advisors' Inner Circle Fund III.